Nuvo Pharmaceuticals Inc. Nuvo (TSX: NRI; OTCQX: NRIFF) is a Canadian focused, healthcare company with global reach and a diversified portfolio of commercial products. The Company targets several therapeutic areas, including pain, allergy and dermatology. The Company’s strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets and to out-license select products in global markets. Nuvo’s head office is located in Mississauga, Ontario, Canada, the Company’s Commercial business is located in Mississauga, Ontario, the international operations are located in Dublin, Ireland and its manufacturing facility is located in Varennes, Québec, Canada. The Varennes facility operates in a Good Manufacturing Practices (GMP) environment respecting the U.S, Canada and E.U. GMP regulations and is regularly inspected by Health Canada and the U.S. Food and Drug Administration. For additional information, please visit www.nuvopharmaceuticals.com.

Contact Information:
Investor Relations
Email: ir@nuvopharm.com

Latest

Jun 26, 2019, 07:30 ET Nuvo Pharmaceuticals™ Announces Director Election Results of its Annual General Meeting and Updates to the Facility Agreement with Deerfield

MISSISSAUGA, ON, June 26, 2019 /CNW/ - Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX: NRI; OTCQX: NRIFF) a Canadian-focused healthcare company with global reach and a diversified portfolio of...


Jun 17, 2019, 08:00 ET Nuvo Pharmaceuticals™ Provides Corporate Update

MISSISSAUGA, ON, June 17, 2019 /CNW/ - Nuvo Pharmaceuticals Inc. ("Nuvo" or "the Company") (TSX:NRI; OTCQX:NRIFF), a Canadian-focused healthcare company with global reach and a diversified portfolio...


May 15, 2019, 13:10 ET Nuvo Pharmaceuticals™ Announces that U.S. Court of Appeals for the Federal Circuit Reverses District Court's Decision Related to Certain Vimovo

MISSISSAUGA, ON, May 15, 2019 /CNW/ - Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX:NRI; OTCQX:NRIFF), a Canadian focused, healthcare company with global reach and a diversified portfolio of...


May 14, 2019, 07:00 ET Nuvo Pharmaceuticals™ Announces 2019 First Quarter Results

- Adjusted Total Revenue Increased 278% to $17.1 million - - Adjusted EBITDA Increased 807% to $5.2 million - - Gross Profit Increased 259% to $9.0 million - - Successfully Integrating Aralez Canada...


Apr 23, 2019, 07:30 ET Nuvo Pharmaceuticals™ to Present at the Bloom Burton & Co. Healthcare Investor Conference

MISSISSAUGA, ON, April 23, 2019 /CNW/ - Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX:NRI; OTCQX:NRIFF), a Canadian focused healthcare company with global reach and a diversified portfolio of...


Apr 02, 2019, 07:30 ET Nuvo Pharmaceuticals™ Announces Pennsaid 2% Marketing Authorization Application Accepted for Review by AGES, the Austrian Agency for Health and Food

MISSISSAUGA, ON, April 2, 2019 /CNW/ - Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX:NRI; OTCQX:NRIFF), a Canadian focused healthcare company with global reach and a diversified portfolio of...


Mar 29, 2019, 07:00 ET Nuvo Pharmaceuticals™ Announces 2018 Fourth Quarter and Year-End Results

- Nuvo to Host Conference Call/Audio Webcast March 29th at 8:00 a.m. ET - MISSISSAUGA, ON, March 29, 2019 /CNW/ - Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX:NRI; OTCQX:NRIFF), a Canadian...


Mar 15, 2019, 07:30 ET Nuvo Pharmaceuticals™ Announces the Filing of the Business Acquisition Report Related to the Acquisition of Aralez Pharmaceuticals Canada, U.S. and

MISSISSAUGA, ON, March 15, 2019 /CNW/ - Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX:NRI; OTCQX:NRIFF) today announced the filing of the Business Acquisition Report (BAR) on SEDAR...


Mar 11, 2019, 07:30 ET Nuvo Pharmaceuticals™ Announces Receipt of Shareholder Approval By Way of Written Consent For the Issuance of Common Shares Pursuant to Convertible

MISSISSAUGA, ON, March 11, 2019 /CNW/ - Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX:NRI; OTCQX:NRIFF) today announced that it has obtained consents from shareholders of the Company...


Jan 03, 2019, 07:30 ET Nuvo Pharmaceuticals™ Announces Appointment of Rob Harris as Executive Chairman

MISSISSAUGA, ON, Jan. 3, 2019 /CNW/ - Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX : NRI; OTCQX : NRIFF), a Canadian focused, healthcare company with global reach and a diversified portfolio...


Jan 02, 2019, 07:30 ET Nuvo Pharmaceuticals™ to Host Conference Call/Audio Webcast to Discuss the Acquisition of Aralez Pharmaceuticals Canada, U.S. and International

- January 2 at 8:30 a.m. ET - MISSISSAUGA, ON, Jan. 2, 2019 /CNW/ - Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX:NRI; OTCQX:NRIFF), a globally focused, Canadian healthcare company with a...


Dec 31, 2018, 11:26 ET Nuvo Pharmaceuticals™ Announces Completion of the Acquisition of Aralez Pharmaceuticals Canada, U.S. and International Rights to Vimovo® and other

- Acquisition expected to result in significant expansion of revenue and adjusted EBITDA - - Acquisition includes more than 20 revenue-generating products - - Acquisition expected to provide platform ...


Dec 21, 2018, 08:30 ET Nuvo Pharmaceuticals™ (Ireland) DAC Enters into Resultz® License and Supply Agreement with Heumann Pharma GmbH & Co. Generica KG for Germany

MISSISSAUGA, ON, Dec. 21, 2018 /CNW/ - Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX:NRI; OTCQX:NRIFF), a globally focused, healthcare company with a portfolio of commercial products and...


Nov 29, 2018, 09:00 ET Nuvo Pharmaceuticals™ Declared Winning Bidder to Acquire Commercial Products from Aralez Pharmaceuticals

- Transaction subject to court approval and other customary conditions - - Closing anticipated by year end - MISSISSAUGA, ON, Nov. 29, 2018 /CNW/ - Nuvo Pharmaceuticals Inc. (Nuvo or the Company)...


Nov 08, 2018, 07:30 ET Nuvo Pharmaceuticals™ Announces 2018 Third Quarter Results

- Nuvo to Host Conference Call/Audio Webcast November 8th at 8:30 a.m. ET - MISSISSAUGA, ON, Nov. 8, 2018 /CNW/ - Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX: NRI) (OTCQX: NRIFF), a globally ...


Sep 19, 2018, 07:02 ET Nuvo Pharmaceuticals™ Announces Signing of Definitive Agreements to Acquire Commercial Products and Infrastructure from Aralez Pharmaceuticals

– Would result in significant expansion of revenue and adjusted EBITDA – – Would provide platform for future growth – – Acquisition financing commitment from Deerfield, a leading, global,...


Sep 19, 2018, 06:54 ET Aralez Pharmaceuticals Enters Into Definitive "Stalking Horse" Purchase Agreements For Substantially All Assets

Aralez Pharmaceuticals Inc. ("Aralez" or the "Company") announced today that it and certain of its affiliates have entered into purchase agreements with two separate stalking-horse purchasers to sell ...


Aug 20, 2018, 07:30 ET Nuvo Pharmaceuticals™ Announces Extension of Exclusivity Period with Aralez and Deerfield

MISSISSAUGA, ON, Aug. 20, 2018 /CNW/ - Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX: NRI) (OTCQX: NRIFF), a globally focused, healthcare company with a portfolio of commercial products and...


Aug 10, 2018, 06:19 ET Nuvo Pharmaceuticals™ Announces Letter of Intent to Acquire Commercial Products and Infrastructure from Aralez Pharmaceuticals

- Would result in significant expansion of revenue and adjusted EBITDA – - Would provide platform for future growth - Acquisition funding proposed to be provided by Deerfield, a leading, global,...


Aug 10, 2018, 06:00 ET Aralez Pharmaceuticals To Enter Into Purchase Agreements To Sell Substantially All Assets

Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ) (TSX: ARZ) ("Aralez" or the "Company") announced today that it intends to enter into purchase agreements with two separate stalking-horse purchasers to sell ...


Aug 02, 2018, 07:30 ET Nuvo Pharmaceuticals™ Announces 2018 Second Quarter Results

- Reports $1.9 million of Adjusted EBITDA on $5.9 million of Revenue - - Finished the Quarter with $8.7 million of Cash and no Debt - - Nuvo to Host Conference Call/Audio Webcast August 2nd at 8:30 a....


Jul 23, 2018, 07:15 ET Nuvo Pharmaceuticals™(Ireland) Limited Enters into Resultz® License and Supply Agreement with Fagron Belgium NV for Belgium, the Netherlands and

MISSISSAUGA, ON, July 23, 2018 /CNW/ - Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX: NRI; OTCQX: NRIFF), a commercial healthcare company with a portfolio of marketed products and...


May 10, 2018, 17:13 ET Nuvo Pharmaceuticals™ Announces Director Election Results of its Annual General Meeting

MISSISSAUGA, ON, May 10, 2018 /CNW/ - Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX: NRI; OTCQX: NRIFF) a commercial healthcare company with a portfolio of commercial products and...


May 10, 2018, 07:00 ET Nuvo Pharmaceuticals™ Announces 2018 First Quarter Results

- Nuvo to Host Conference Call/Audio Webcast May 10th at 7:45 a.m. ET - MISSISSAUGA, ON, May 10, 2018 /CNW/ - Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX:NRI; OTCQX:NRIFF), a commercial...


Apr 16, 2018, 08:35 ET Nuvo Pharmaceuticals Inc. Presentation Now Available for On-Demand Viewing

Nuvo Pharmaceuticals Inc. (OTCQX: NRIFF, TSX:NRI), based in Canada, focused on healthcare products and pharmaceuticals, today announced that the April 11th presentation from Jesse Ledger, Nuvo's...